Blackstone’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Blackstone's REGN Position: Q2 2026 in Review
Blackstone opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 2,516 shares worth $1.57M. The stake represents ﹤0.01% of the portfolio and ranks #203 among its holdings.
1,346 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Blackstone held 2,516 shares of Regeneron Pharmaceuticals worth $1.57M as of Q2 2026.
- Regeneron Pharmaceuticals was a new Blackstone position in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #203 holding.
- 1,346 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.